Japan Infectious Respiratory Disease Diagnostics Market Size & Outlook

The infectious respiratory disease diagnostics market in Japan is expected to reach a projected revenue of US$ 680.9 million by 2028. A compound annual growth rate of 7.1% is expected of Japan infectious respiratory disease diagnostics market from 2021 to 2028.
Revenue, 2020 (US$M)
$392.7
Forecast, 2028 (US$M)
$680.9
CAGR, 2021 - 2028
7.1%
Report Coverage
Japan

Japan infectious respiratory disease diagnostics market, 2016-2028 (US$M)

Japan

Related Markets

Japan infectious respiratory disease diagnostics market highlights

  • The Japan infectious respiratory disease diagnostics market generated a revenue of USD 392.7 million in 2020 and is expected to reach USD 680.9 million by 2028.
  • The Japan market is expected to grow at a CAGR of 7.1% from 2021 to 2028.
  • In terms of segment, consumables was the largest revenue generating product in 2020.
  • Consumables is the most lucrative product segment registering the fastest growth during the forecast period.


Infectious respiratory disease diagnostics market data book summary

Market revenue in 2020USD 392.7 million
Market revenue in 2028USD 680.9 million
Growth rate7.1% (CAGR from 2020 to 2028)
Largest segmentConsumables
Fastest growing segmentConsumables
Historical data2016 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Consumables, Services
Key market players worldwideAbbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche


Other key industry trends

  • In terms of revenue, Japan accounted for 1.1% of the global infectious respiratory disease diagnostics market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Asia Pacific, India infectious respiratory disease diagnostics market is projected to lead the regional market in terms of revenue in 2028.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 680.9 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Respiratory Disease Diagnostics Market Scope

Infectious respiratory disease diagnostics market segmentation & scope
Respiratory Measurment Devices
Imaging tests
Other Instruments
Consumables
Services
Saliva
Nasopharyngeal Swabs (NPS)
Anterior Nasal Region
Blood
Others
Immunoassay
Molecular Diagnostics
Microbiology
Other technologies
COVID-19
Influenza
RSV (Respiratory Syncytial Virus)
Tuberculosis
Streptococcus Testing
Other Respiratory Disease Testing
Hospitals
Diagnostic Laboratories
Physician Offices
Other end-users

Infectious Respiratory Disease Diagnostics Market Companies

Name Profile # Employees HQ Website

Japan infectious respiratory disease diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.


Consumables was the largest segment with a revenue share of 60.17% in 2020. Horizon Databook has segmented the Japan infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2016 to 2028.


The infectious respiratory disease diagnostics market in Japan is estimated to witness the significant growth during the forecast period owing to the presence of well-established public healthcare system, trained public health workers, and efficient healthcare services in educational centers in the country.

These factors have significantly contributed to the rapidly reducing mortality rates due to infectious diseases. Key factors driving the growth of the market in this country include high prevalence of infectious respiratory diseases, rise in awareness about nucleic acid testing, and increase in geriatric population that is susceptible to infectious diseases.

The country performed around 15 million tests, as of June 2021. Furthermore, as of March 2021, around 40,000 PCR tests are being conducted per day. This significant data is indicative of the market growth in Japan. Increasing approval of diagnostic products for COVID-19 by healthcare authority of Japan, to increase testing capacity in the country, is boosting market growth.

Reasons to subscribe to Japan infectious respiratory disease diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan infectious respiratory disease diagnostics market databook

  • Our clientele includes a mix of infectious respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan infectious respiratory disease diagnostics market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan infectious respiratory disease diagnostics market size, by product, 2016-2028 (US$M)

Japan Infectious Respiratory Disease Diagnostics Market Outlook Share, 2020 & 2028 (US$M)

Japan infectious respiratory disease diagnostics market size, by product, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more